Failure to affect tissue reserpine concentrations by alteration of adrenergic nerve activity.
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D002714:Chlorisondamine / Q000494:pharmacology; D003080:Cold Temperature; D004298:Dopamine / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology; D007421:Intestine, Small / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D010627:Phenethylamines / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000378:metabolism*; D013154:Spleen / Q000378:metabolism; D013312:Stress, Physiological / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D014316:Tritium
D007328:Insulin; D010627:Phenethylamines; D010643:Phenoxybenzamine; D014316:Tritium; D012110:Reserpine; D002714:Chlorisondamine; D004298:Dopamine; D009638:Norepinephrine